Admission to trading on OTCQB in the US

Summary by AI BETAClose X

Abingdon Health plc has announced the admission of its ordinary shares to trading on the OTCQB Venture Market in the United States under the ticker symbol ABDXF, effective today. This listing on the OTCQB is designed for development stage companies and, as a foreign private issuer, Abingdon Health will not face additional reporting obligations or incur significant extra costs due to its exemption under US Exchange Act Rule 12g3-2(b), provided it continues to make information available to US investors in English as required by its home market regulator. The company's ordinary shares will continue to trade on the London Stock Exchange's AIM Market under the symbol ABDX.

Disclaimer*

UK 100

Latest directors dealings